{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T23:33:12Z","timestamp":1792193592654,"version":"4.4.0"},"reference-count":47,"publisher":"Public Library of Science (PLoS)","issue":"4","license":[{"start":{"date-parts":[[2022,4,14]],"date-time":"2022-04-14T00:00:00Z","timestamp":1649894400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"NWO","award":["NWO Gravitation project (024.003.001) funded by the Ministry of Education, Culture and Science of the government of the Netherlands"],"award-info":[{"award-number":["NWO Gravitation project (024.003.001) funded by the Ministry of Education, Culture and Science of the government of the Netherlands"]}]},{"name":"Health Holland","award":["MONACO-SPRINT (LSHM20063) co-funded by the PPP Allowance made available by Health-Holland; Top Sector Life Sciences & Health and Health Holland Organ On Chip grant"],"award-info":[{"award-number":["MONACO-SPRINT (LSHM20063) co-funded by the PPP Allowance made available by Health-Holland; Top Sector Life Sciences & Health and Health Holland Organ On Chip grant"]}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:p>The use of Engineered Heart Tissues (EHT) as <jats:italic>in vitro<\/jats:italic> model for disease modeling and drug screening has increased, as they provide important insight into the genetic mechanisms, cardiac toxicity or drug responses. Consequently, this has highlighted the need for a standardized, unbiased, robust and automatic way to analyze hallmark physiological features of EHTs. In this study we described and validated a standalone application to analyze physiological features of EHTs in an automatic, robust, and unbiased way, using low computational time. The standalone application \u201c<jats:italic>EHT Analysis<\/jats:italic>\u201d contains two analysis modes (automatic and manual) to analyzes the contractile properties and the contraction kinetics of EHTs from high speed bright field videos. As output data, the graphs of displacement, contraction force and contraction kinetics per file will be generated together with the raw data. Additionally, it also generates a summary file containing all the data from the analyzed files, which facilitates and speeds up the post analysis. From our study we highlight the importance of analyzing the axial stress which is the force per surface area (\u03bcN\/mm<jats:sup>2<\/jats:sup>). This allows to have a readout overtime of tissue compaction, axial stress and leave the option to calculate at the end point of an experiment the physiological cross-section area (PSCA). We demonstrated the utility of this tool by analyzing contractile properties and compaction over time of EHTs made out of a double reporter human pluripotent stem cell (hPSC) line (NKX2.5<jats:sup>EGFP\/+-<\/jats:sup>COUP-TFII<jats:sup>mCherry\/+<\/jats:sup>) and different ratios of human adult cardiac fibroblasts (HCF). Our standalone application \u201cEHT Analysis\u201d can be applied for different studies where the physiological features of EHTs needs to be analyzed under the effect of a drug compound or in a disease model.<\/jats:p>","DOI":"10.1371\/journal.pone.0266834","type":"journal-article","created":{"date-parts":[[2022,4,14]],"date-time":"2022-04-14T17:30:55Z","timestamp":1649957455000},"page":"e0266834","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":19,"title":["Contractility analysis of human engineered 3D heart tissues by an automatic tracking technique using a standalone application"],"prefix":"10.1371","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0075-6006","authenticated-orcid":true,"given":"Jos\u00e9 M.","family":"Rivera-Arbel\u00e1ez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carla","family":"Cofi\u00f1o-Fabres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Verena","family":"Schwach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom","family":"Boonen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simone A.","family":"ten Den","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kim","family":"Vermeul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albert","family":"van den Berg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Loes I.","family":"Segerink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcelo C.","family":"Ribeiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Passier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2022,4,14]]},"reference":[{"key":"pone.0266834.ref001","doi-asserted-by":"crossref","first-page":"e558","DOI":"10.1161\/CIR.0000000000000570","article-title":"Projected Costs of Informal Caregiving for Cardiovascular Disease: 2015 to 2035: A Policy Statement From the American Heart Association","volume":"137","author":"SB Dunbar","year":"2018","journal-title":"Circulation"},{"key":"pone.0266834.ref002","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/S0167-5273(15)31026-3","article-title":"Global burden of CVD: Focus on secondary prevention of cardiovascular disease.","volume":"201","author":"S Bansilal","year":"2015","journal-title":"Int J Cardiol"},{"key":"pone.0266834.ref003","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1093\/eurheartj\/ehz859","article-title":"European society of cardiology: Cardiovascular disease statistics 2019","volume":"41","author":"A Timmis","year":"2020","journal-title":"Eur Heart J"},{"key":"pone.0266834.ref004","first-page":"1","article-title":"Projections of Cardiovascular Disease Prevalence and Costs: 2015\u20132035.","author":"O Khavjou","year":"2016","journal-title":"RTI Int"},{"key":"pone.0266834.ref005","doi-asserted-by":"crossref","first-page":"8352","DOI":"10.1002\/jcp.27729","article-title":"Organ-on-chip models: Implications in drug discovery and clinical applications","volume":"234","author":"R Mittal","year":"2019","journal-title":"J Cell Physiol"},{"key":"pone.0266834.ref006","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.tiv.2017.03.012","article-title":"Architecture in 3D cell culture: An essential feature for in vitro toxicology","volume":"45","author":"SA Leli\u00e8vre","year":"2017","journal-title":"Toxicol Vitr"},{"key":"pone.0266834.ref007","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1016\/j.stemcr.2018.10.008","article-title":"Atrial-like Engineered Heart Tissue: An In Vitro Model of the Human Atrium.","volume":"11","author":"M Lemme","year":"2018","journal-title":"Stem Cell Reports"},{"key":"pone.0266834.ref008","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.stemcr.2016.04.011","article-title":"Human Engineered Heart Tissue: Analysis of Contractile Force.","volume":"7","author":"I Mannhardt","year":"2016","journal-title":"Stem Cell Reports"},{"key":"pone.0266834.ref009","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a023200","article-title":"Muscle contraction.","volume":"10","author":"HL Sweeney","year":"2018","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"pone.0266834.ref010","doi-asserted-by":"crossref","first-page":"787","DOI":"10.2174\/1389201021666191210142023","article-title":"Human Heart Cardiomyocytes in Drug Discovery and Research: New Opportunities in Translational Sciences.","volume":"21","author":"N Abi-Gerges","year":"2019","journal-title":"Curr Pharm Biotechnol"},{"key":"pone.0266834.ref011","article-title":"Engineered models of the human heart: directions and challenges.","author":"JM Stein","year":"2020","journal-title":"Stem Cell Reports"},{"key":"pone.0266834.ref012","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/j.stem.2019.03.009","article-title":"Drug Screening in Human PSC-Cardiac Organoids Identifies Pro-proliferative Compounds Acting via the Mevalonate Pathway","volume":"24","author":"RJ Mills","year":"2019","journal-title":"Cell Stem Cell"},{"key":"pone.0266834.ref013","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/j.cell.2018.11.042","article-title":"A Platform for Generation of Chamber-Specific Cardiac Tissues and Disease Modeling","volume":"176","author":"Y Zhao","year":"2019","journal-title":"Cell"},{"key":"pone.0266834.ref014","doi-asserted-by":"crossref","first-page":"26397","DOI":"10.1371\/journal.pone.0026397","article-title":"Human Engineered Heart Tissue as a Versatile Tool in Basic Research and Preclinical Toxicology.","volume":"6","author":"S Schaaf","year":"2011","journal-title":"PLoS One"},{"key":"pone.0266834.ref015","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1093\/toxsci\/kfz168","article-title":"Engineered Cardiac Tissues Generated in the Biowire II: A Platform for Human-Based Drug Discovery","volume":"172","author":"NT Feric","year":"2019","journal-title":"Toxicol Sci"},{"key":"pone.0266834.ref016","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1016\/j.stemcr.2018.01.039","article-title":"Contractile Work Contributes to Maturation of Energy Metabolism in hiPSC-Derived Cardiomyocytes","volume":"10","author":"BM Ulmer","year":"2018","journal-title":"Stem Cell Reports"},{"key":"pone.0266834.ref017","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1002\/stem.2732","article-title":"Passive Stretch Induces Structural and Functional Maturation of Engineered Heart Muscle as Predicted by Computational Modeling","volume":"36","author":"OJ Abilez","year":"2018","journal-title":"Stem Cells"},{"key":"pone.0266834.ref018","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/s41586-018-0016-3","article-title":"Advanced maturation of human cardiac tissue grown from pluripotent stem cells","volume":"556","author":"K Ronaldson-Bouchard","year":"2018","journal-title":"Nature"},{"key":"pone.0266834.ref019","article-title":"Inotropic assessment in engineered 3D cardiac tissues using human induced pluripotent stem cell-derived cardiomyocytes in the BiowireTM II platform","volume":"105","author":"Y Qu","year":"2020","journal-title":"J Pharmacol Toxicol Methods"},{"key":"pone.0266834.ref020","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/j.stemcr.2020.09.002","article-title":"Comparison of 10 Control hPSC Lines for Drug Screening in an Engineered Heart Tissue Format.","volume":"15","author":"I Mannhardt","year":"2020","journal-title":"Stem Cell Reports"},{"key":"pone.0266834.ref021","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1016\/j.stemcr.2017.10.024","article-title":"A COUP-TFII Human Embryonic Stem Cell Reporter Line to Identify and Select Atrial Cardiomyocytes.","volume":"9","author":"V Schwach","year":"2017","journal-title":"Stem Cell Reports"},{"key":"pone.0266834.ref022","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.celrep.2015.09.025","article-title":"Contractile Defect Caused by Mutation in MYBPC3 Revealed under Conditions Optimized for Human PSC-Cardiomyocyte Function","volume":"13","author":"MJ Birket","year":"2015","journal-title":"Cell Rep"},{"key":"pone.0266834.ref023","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1038\/nprot.2008.42","article-title":"A protocol describing the use of a recombinant protein-based, animal product-free medium (APEL) for human embryonic stem cell differentiation as spin embryoid bodies.","volume":"3","author":"ES Ng","year":"2008","journal-title":"Nat Protoc"},{"key":"pone.0266834.ref024","unstructured":"PromoCell. Instruction Manual. n.d."},{"key":"pone.0266834.ref025","doi-asserted-by":"crossref","first-page":"214","DOI":"10.3390\/jpm12020214","article-title":"A New Versatile Platform for Assessment of Improved Cardiac Performance in Human-Engineered Heart Tissues.","volume":"12","author":"MC Ribeiro","year":"2022","journal-title":"J Pers Med"},{"key":"pone.0266834.ref026","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1109\/TSMC.1979.4310076","article-title":"Threshold Selection Method from Gray-Level Histograms","volume":"SMC-9","author":"N. Otsu","year":"1979","journal-title":"IEEE Trans Syst Man Cybern"},{"key":"pone.0266834.ref027","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1089\/ten.tea.2011.0278","article-title":"Myocyte-depleted engineered cardiac tissues support therapeutic potential of mesenchymal stem cells","volume":"18","author":"GW Serrao","year":"2012","journal-title":"Tissue Eng\u2014Part A"},{"key":"pone.0266834.ref028","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCULATIONAHA.105.001560","article-title":"Optimizing engineered heart tissue for therapeutic applications as surrogate heart muscle","volume":"114","author":"H Naito","year":"2006","journal-title":"Circulation"},{"key":"pone.0266834.ref029","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/1755-1536-5-15","article-title":"Cardiac fibroblasts, fibrosis and extracellular matrix remodeling in heart disease","volume":"5","author":"D Fan","year":"2012","journal-title":"Fibrogenesis Tissue Repair"},{"key":"pone.0266834.ref030","doi-asserted-by":"crossref","first-page":"0510051","DOI":"10.1115\/1.4027145","article-title":"Measuring the Contractile Forces of Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes With Arrays of Microposts","volume":"136","author":"ML Rodriguez","year":"2014","journal-title":"J Biomech Eng"},{"key":"pone.0266834.ref031","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.yjmcc.2018.03.016","article-title":"Afterload promotes maturation of human induced pluripotent stem cell derived cardiomyocytes in engineered heart tissues","volume":"118","author":"A Leonard","year":"2018","journal-title":"J Mol Cell Cardiol"},{"key":"pone.0266834.ref032","doi-asserted-by":"crossref","first-page":"e0198026","DOI":"10.1371\/journal.pone.0198026","article-title":"Contractile force measurement of human induced pluripotent stem cell-derived cardiac cell sheet-tissue","volume":"13","author":"D Sasaki","year":"2018","journal-title":"PLoS One"},{"key":"pone.0266834.ref033","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1096\/fj.13-228007","article-title":"Advancing functional engineered cardiac tissues toward a preclinical model of human myocardium","volume":"28","author":"IC Turnbull","year":"2014","journal-title":"FASEB J"},{"key":"pone.0266834.ref034","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/term.2755","article-title":"Piezo-bending actuators for isometric or auxotonic contraction analysis of engineered heart tissue","volume":"13","author":"I Mannhardt","year":"2019","journal-title":"J Tissue Eng Regen Med"},{"key":"pone.0266834.ref035","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1161\/CIRCULATIONAHA.116.024145","article-title":"Defined engineered human myocardium with advanced maturation for applications in heart failure modeling and repair","volume":"135","author":"M Tiburcy","year":"2017","journal-title":"Circulation"},{"key":"pone.0266834.ref036","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1161\/CIRCRESAHA.109.211458","article-title":"Development of a drug screening platform based on engineered heart tissue","volume":"107","author":"A Hansen","year":"2010","journal-title":"Circ Res"},{"key":"pone.0266834.ref037","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/S0091-679X(07)83013-5","article-title":"Microfabricated Silicone Elastomeric Post Arrays for Measuring Traction Forces of Adherent Cells.","volume":"83","author":"NJ Sniadecki","year":"2007","journal-title":"Methods Cell Biol"},{"key":"pone.0266834.ref038","article-title":"MUSCLEMOTION: A Versatile Open Software Tool to Quantify Cardiomyocyte and Cardiac Muscle Contraction In Vitro and In Vivo","author":"L Sala","year":"2017","journal-title":"Circ Res"},{"key":"pone.0266834.ref039","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1161\/CIRCULATIONAHA.116.024145","article-title":"Defined Engineered Human Myocardium with Advanced Maturation for Applications in Heart Failure Modelling and Repair","volume":"135","author":"M Tiburcy","year":"2017","journal-title":"Circulation"},{"key":"pone.0266834.ref040","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0198026","article-title":"Contractile force measurement of human induced pluripotent stem cell-derived cardiac cell sheet-tissue","volume":"13","author":"D Sasaki","year":"2018","journal-title":"PLoS One"},{"key":"pone.0266834.ref041","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1161\/CIRCULATIONAHA.114.014998","article-title":"Mechanical Stress Conditioning and Electrical Stimulation Promote Contractility and Force Maturation of Induced Pluripotent Stem Cell-Derived Human Cardiac Tissue","volume":"134","author":"JL Ruan","year":"2016","journal-title":"Circulation"},{"key":"pone.0266834.ref042","doi-asserted-by":"crossref","DOI":"10.1038\/srep29933","article-title":"The myocardial regenerative potential of three-dimensional engineered cardiac tissues composed of multiple human iPS cell-derived cardiovascular cell lineages","volume":"6","author":"H Masumoto","year":"2016","journal-title":"Sci Rep"},{"key":"pone.0266834.ref043","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1161\/CIRCRESAHA.110.237206","article-title":"Growth of engineered human myocardium with mechanical loading and vascular coculture","volume":"109","author":"NL Tulloch","year":"2011","journal-title":"Circ Res"},{"key":"pone.0266834.ref044","first-page":"1","article-title":"Generating ring-shaped engineered heart tissues from ventricular and atrial human pluripotent stem cell-derived cardiomyocytes","volume":"111","author":"I Goldfracht","year":"2020","journal-title":"Nat Commun"},{"key":"pone.0266834.ref045","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.pharmthera.2009.05.002","article-title":"Cardiac fibroblasts: at the heart of myocardial remodeling","volume":"123","author":"KE Porter","year":"2009","journal-title":"Pharmacol Ther"},{"key":"pone.0266834.ref046","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.1311120110","article-title":"Design and formulation of functional pluripotent stem cell-derived cardiac microtissues","volume":"110","author":"N Thavandiran","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"pone.0266834.ref047","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1021\/acscentsci.9b00052","article-title":"Biowire Model of Interstitial and Focal Cardiac Fibrosis.","volume":"5","author":"EY Wang","year":"2019","journal-title":"ACS Cent Sci"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0266834","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,14]],"date-time":"2022-04-14T17:31:39Z","timestamp":1649957499000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0266834"}},"subtitle":[],"editor":[{"given":"Xiaoping","family":"Bao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2022,4,14]]},"references-count":47,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2022,4,14]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0266834","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,14]]}}}